A phase I study of TRC105 anti‐endoglin (CD105) antibody in metastatic castration‐resistant prostate cancer

Publisher: John Wiley & Sons Inc

E-ISSN: 1464-410x|116|4|546-555

ISSN: 1464-4096

Source: BJU INTERNATIONAL, Vol.116, Iss.4, 2015-10, pp. : 546-555

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract